Skip to main content
Premium Trial:

Request an Annual Quote

Take It Down

Publishing company Elsevier has issued takedown notices not only to the social media site, but also to universities to remove certain journal articles from their sites, the Washington Post's The Switch blog reports.

Elsevier, the blog notes, typically requires researchers to sign over copyright of the paper to them before they publish it, and therefore the company has the justification ask for copies of the papers to be removed from other sites.

Richard Price, the CEO of, tells The Switch blog's Andrea Peterson that his firm usually received a takedown notice or two a week, but recently has received some 2,800 requests from Elsevier. Around the same time, universities like the University of Calgary, the University of California, Irvine, and Harvard University received notices to remove article appearing on departmental, faculty, and class websites, Peterson notes.

"We had not received takedown notices for scholarly articles before this, as far as we know," Peter Suber, the Director of the Harvard Office for Scholarly Communication and the Harvard Open Access Project, tells Peterson.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.